Search | IOVS | ARVO Journals

View

Showing 1 – 8 of 8

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate with Extended Durability, in wAMD, DME, and RVO

Sunil S Patel; Daniel Janer; Bryce Miller; Jason S Ehrlich; Victor Perlroth; J. Pablo Velazquez-Martin

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4286. doi:

ARVO Annual Meeting Abstract July 2019

Phase 1 first-in-human study of KSI-301: a novel anti-VEGF antibody biopolymer conjugate with extended durability

Sunil S Patel; Joel Naor; Almas Qudrat; Diana V Do; Desiree Buetelspacher; hong liang; D. Victor Perlroth

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3670. doi:

ARVO Annual Meeting Abstract July 2018

Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial

Sunil S Patel; Jayashree Sahni; Shamil Sadikhov; Meike Pauly-Evers; Piotr Szczesny; Robert Weikert

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1959. doi:

ARVO Annual Meeting Abstract June 2017

Brimonidine Drug Delivery System (DDS) Generation 1 in patients with geographic atrophy: Post-hoc analysis of a phase 2 study

Baruch D Kuppermann; Sunil S Patel; David S Boyer; Albert J Augustin; William R Freeman; Thomas Kim; Kevin Kerr; Francisco J Lopez; Susan Schneider

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1924. doi:

ARVO Annual Meeting Abstract June 2017

Patient-, caregiver-, and healthcare provider-reported burden of geographic atrophy

Sunil S Patel; Rishi P Singh; Jared S Nielsen; Jordana Schmier; Yamina Rajput

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1523. doi:

ARVO Annual Meeting Abstract June 2015

A Phase 1 Safety Study of an Orally Available Tyrosine Kinase Inhibitor X-82 in Previously Treated Wet AMD Patients

Philip J Rosenfeld; Jason S Slakter; David S Boyer; David M Brown; Nauman A Chaudhry; Michael J Elman; Sunil S Patel; Denis O’Shaughnessy

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4804. doi:

ARVO Annual Meeting Abstract June 2013

Truck Drivers Suffer Significant Economic Harm Due to Diabetic Macular Edema

Sunil Patel; Colleen Peters; Kristen Garcia; Angela Jaimes; Bryce Miller; Steven Kymes; Adam Turpcu

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2369. doi:

ARVO Annual Meeting Abstract April 2011

Dexamethasone Intravitreal Implant (DEX Implant) Alone And As An Adjunct To Ranibizumab For The Treatment Of Choroidal Neovascularization (CNV) Secondary To Age-related Macular Degeneration (AMD)

Michael Singer; Sunil S. Patel; Harvey S. Uy; Ching-Chi Liu; Xiao-Yan Li; Scott M. Whitcup

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3536. doi:

Advertisement